AARP Benefits Financially From Medicare Prescription Drug Benefit It Helped Pass

Main Category: Medicare / Medicaid / SCHIP
Article Date: 21 Dec 2007 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (7 votes)

Healthcare Prof:5 stars

5 (1 votes)

Article Opinions: 1 posts

Some advocates have expressed concern over the commercial success of AARP-branded Medicare prescription drug plans, administered by UnitedHealthcare Services, the Philadelphia Inquirer reports. AARP's Medicare drug plans account for the No. 1 selling plan in the nation -- the AARP MedicareRX Preferred -- and two others in the top five, though they "often cost hundreds of dollars" more annually than the lowest-priced competing plans, according to the Inquirer. The three plans trump the sales of any other brand of drug plans, including those marketed by UnitedHealthcare that do not carry the AARP name.

According to the Inquirer, "While its cachet comes from advocacy, AARP is also an entrepreneurial juggernaut that profits from the Medicare drug benefit it helped pass." However, Judith Stein, executive director of the Center for Medicare Advocacy, said she is concerned about AARP's dual role as an advocate and commercial enterprise. Stein said, "The privatization of Medicare in general is a very bad thing and a good thing for the companies that are making a huge profit. When one of those companies is benefited by the AARP brand, I think it's a conflict."

Experts attribute the success of AARP's plans to appeal of the brand and the trust consumers have in the organization. "It's peace of mind. That's why AARP/United is able to get a premium," according to Richard Stefanacci, director of the Center for Medicare Medication Management at the University of the Sciences in Philadelphia. The Inquirer reports, "As the Dec. 31 deadline approaches for Medicare members to change plans or sign up, many seniors are choosing AARP to cut through the clutter of a confounding marketplace." The not-for-profit reached $1 billion in revenue last year and expects to see $4.4 billion in sales over the next seven years from new deals with Aetna and UnitedHealthcare (Stark, Philadelphia Inquirer, 12/20).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our medicare / medicaid / schip section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "AARP Benefits Financially From Medicare Prescription Drug Benefit It Helped Pass." Medical News Today. MediLexicon, Intl., 21 Dec. 2007. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/92508.php>

APA
Kaiser. (2007, December 21). "AARP Benefits Financially From Medicare Prescription Drug Benefit It Helped Pass." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/92508.php.

Please note: If no author information is provided, the source is cited instead.


Medicare / Medicaid / SCHIP

What is Medicare / Medicaid?

Medicaid and Medicare are two governmental programs that provide medical and health-related services to specific groups of people in the United States. Although the two programs are very different, they are both managed by the Centers for Medicare and... Read more...

Most Popular Articles



Follow Our Medicare News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Medicare / Medicaid / SCHIP Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »